GL1X · GenesisL1 explorer

MolNFT v1 · #191417 · protein

Crystal structure of human KRAS G12C covalently bound with taiho WO2020/085493A1 compound 6

8DNK · Isoform 2B of GTPase KRAS: “Crystal structure of human KRAS G12C covalently bound with taiho WO2020/085493A1 compound 6”. X-ray diffraction, 4 ligands (GDP, U50, MG), 1 pocket (best druggability 0.71). MolNFT v1 #191417 on…

PDB
8DNK
Type
protein
Length
169 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Isoform 2B of GTPase KRAS
EC
3.6.5.2
Ligands
GDP, U50, MG, SO4
Pockets
1 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIsoform 2B of GTPase KRAS (EC 3.6.5.2)protein16937% helix, 25% strand—

Ligands and binding sites

  • GDP · Guanosine-5'-diphosphate · ligand · chains A
  • U50 · 2-{[(5-tert-butyl-6-chloro-1H-indazol-3-yl) amino]methyl}-4-chloro-1-methyl-N-(1-propanoylazetidin-3-yl)-1H-imidazole-5-carboxamide · ligand · chains A
  • MG · Magnesium ion · metal · chains A
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13380.710.8447MG, GDP, U50

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 8DNK · Crystal structure of human KRAS G12C covalently bound with Taiho WO2020/085493A1 compound… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.